Internal Medicine · Brooklyn, NY
NPI
1396792594
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
7 Corbin Pl Ste C1
Brooklyn, NY, 11235
Phone (347) 391-6166
Groups this clinician bills Medicare through
Medicare paid, 2024
$239K
3,597 services
Medicare patients, 2024
343
Average age 79
Drug cost, 2024
$2.0M
13,494 prescriptions
Company payments, 2025
$2,112
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ali Khusseyn was code 99213 (office e&m - established), 873 times for 233 patients. In total Ali Khusseyn billed 3,597 services in 50 codes, and Medicare paid $239K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 873 | 233 | $76.09 | $66K |
| 99491 Chronic, Principal, and Transitional Care Management | Office | 492 | 49 | $74.44 | $37K |
| 99214 Office E&M - Established | Office | 248 | 130 | $105.57 | $26K |
| 99497 Care Management/Coordination | Office | 214 | 214 | $88.12 | $19K |
| 36415 Venipuncture Blood Collection | Office | 213 | 135 | $7.90 | $1,684 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 191 | 191 | $27.92 | $5,333 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 184 | 184 | $144.75 | $27K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 167 | 167 | $21.32 | $3,560 |
| 93000 Electrocardiogram | Office | 112 | 88 | $11.93 | $1,337 |
| 99233 Hospital E&M - Subsequent | Facility | 94 | 65 | $104.80 | $9,851 |
| G0008 Administration of influenza virus vaccine | Office | 93 | 93 | $37.09 | $3,449 |
| 99212 Office E&M - Established | Office | 92 | 68 | $44.91 | $4,132 |
| 90662 Vaccine Product | Office | 91 | 91 | $81.82 | $7,446 |
| 96372 Injection Administration | Office | 58 | 26 | $12.38 | $718 |
| 99232 Hospital E&M - Subsequent | Facility | 49 | 35 | $69.65 | $3,413 |
By year: 2022 $240K for 3,698 services; 2023 $253K for 3,824 services; 2024 $239K for 3,597 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 213 | 135 | $7.90 | $1,684 |
Medicare prescription drug claims, 2024
In 2024, the drug Ali Khusseyn prescribed most often to Medicare patients was Amlodipine Besylate, with 624 prescriptions and refills. In total Ali Khusseyn wrote 13,494 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 624 | 857 | 95 | $1,451 |
| Atorvastatin Calcium Generic | 463 | 716 | 77 | $2,018 |
| Metoprolol Succinate Generic | 456 | 613 | 61 | $3,758 |
| Rosuvastatin Calcium Generic | 435 | 599 | 70 | $2,299 |
| Losartan Potassium Generic | 380 | 603 | 69 | $1,609 |
| Omeprazole Generic | 361 | 449 | 52 | $1,609 |
| Diclofenac Sodium Generic | 330 | 342 | 51 | $176K |
| Metformin Hcl Generic | 304 | 419 | 43 | $1,055 |
| Tamsulosin Hcl Generic | 260 | 365 | 39 | $1,703 |
| Eliquis Apixaban | 258 | 277 | 33 | $168K |
| Clopidogrel Clopidogrel Bisulfate | 246 | 330 | 31 | $783 |
| Linzess Linaclotide | 226 | 260 | 35 | $128K |
| Gabapentin Generic | 219 | 237 | 35 | $1,398 |
| Vascepa Icosapent Ethyl | 210 | 238 | 38 | $80K |
| Hydrochlorothiazide Generic | 207 | 323 | 34 | $359 |
Brand drugs: 3,172 claims; generic drugs: 10,131 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ali Khusseyn $2,112 ($2,112 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $501.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $501 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $393 |
| Eisai Inc. 4523.T | 13 | $346 |
| Axsome Therapeutics, Inc. AXSM | 7 | $155 |
| Lundbeck LLC | 5 | $107 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $103 |
| Ardelyx, Inc. ARDX | 3 | $91.91 |
| Neurelis, Inc. | 3 | $80.51 |
| Azurity Pharmaceuticals, Inc. | 4 | $75.31 |
| ACADIA Pharmaceuticals Inc ACAD | 2 | $56.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.